image

Image Credits: Honou / Flickr (Sky background)

Citing concerns over “aerosol exposure to Ebola,” the Pentagon awarded a $9.5 million contract to a biotechnology company to manufacture an Ebola vaccine.

The company, Profectus BioSciences, announced todaythat the Pentagon “contracted the manufacture and … preclinical testing of the Profectus trivalent Ebola/Marburg vaccine” which had previously been tested to “confirm protection of non-human primates from aerosol exposure to Ebola and Marburg viruses.”

“In July 2014, Profectus BioSciences and the GNL were awarded a 3 year, $8.5M grant from the DOD/Joint Vaccine Acquisition Program to support development of a lyophilized trivalent VesiculoVax™-vectored vaccine to protect against all major strains of Ebola and Marburg viruses delivered as aerosols,” the press release stated. “The lyophilized trivalent vaccine is being tested in both pre-exposure and post-exposure studies to confirm protection of non-human primates from aerosol exposure to Ebola and Marburg viruses.”

The development of this vaccine stemmed from the Pentagon’s concern over the airborne transmission of filoviruses such as Ebola which the Centers for Disease Control and Prevention finally admitted spreads like the flu through coughing and sneezing.

The Pentagon took the threat so seriously that it hosted a “Filovirus Medical Countermeasures Workshop” in 2013 which “brought together government, academic and industry experts” to underscore its Ebola vaccine requirements.

Written by Kit Daniels
Read more at Infowars

Leave a Reply